FindTrial
Sign In

Research on the Prevention and Treatment of Comorbidity in Metabolic and Skin Diseases

Research on the Prevention and Treatment of Comorbidity in Metabolic and Skin Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105988
Enrollment
Unknown
Registered
2025-07-15
Start date
2025-06-20
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune-mediated dermatological conditions such as psoriasis and IgA vasculitis

Interventions

Healthy control group:NA
Comorbidity group:NA

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients definitively diagnosed with immune-mediated dermatological diseases (psoriasis, bullous pemphigoid, IgA vasculitis, atopic dermatitis) and/or clinically confirmed metabolic disorders (fatty liver disease, diabetes).

Exclusion criteria

Exclusion criteria: 1.Patients with severe acute infections; 2.patients with immunodeficiency and infectious diseases, HIV patients and syphilis patients; 3.psychiatric patients;

Design outcomes

Primary

MeasureTime frame
Distribution of comorbidity types;disease incidence rate;—

Secondary

MeasureTime frame
Changes in metabolic indicators;—

Countries

China

Contacts

Public ContactYanyan Zhu

Xi'an Jiaotong University Second Affiliated Hospital

zhuyanyan2018@mail.xjtu.edu.cn+86 15736786051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026